Literature DB >> 16769402

Secondary transmission of varicella vaccine virus in a chronic care facility for children.

Richard Grossberg1, Rafael Harpaz, Elena Rubtcova, Vladimir Loparev, Jane F Seward, D Scott Schmid.   

Abstract

A 16-year-old varicella-seronegative resident at a chronic care facility received varicella vaccine; 15 days later he developed severe varicella. Subsequently, a 13-year-old resident and a 39-year-old health care worker developed mild varicella. We demonstrate that vaccine-strain virus was transmitted to both persons, and that transmission included at least 2 variant vaccine strains.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16769402     DOI: 10.1016/j.jpeds.2006.01.038

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  11 in total

1.  Novel genetic variation identified at fixed loci in ORF62 of the Oka varicella vaccine and in a case of vaccine-associated herpes zoster.

Authors:  Mark L Quinlivan; Nancy J Jensen; Kay W Radford; D Scott Schmid
Journal:  J Clin Microbiol       Date:  2012-02-29       Impact factor: 5.948

Review 2.  Transmission of Vaccine-Strain Varicella-Zoster Virus: A Systematic Review.

Authors:  Mona Marin; Jessica Leung; Anne A Gershon
Journal:  Pediatrics       Date:  2019-09       Impact factor: 7.124

3.  Vaccine-related varicella-zoster rash in a hospitalized immunocompetent patient.

Authors:  Paul Bernstein; Yoko Furuya; Sharon Steinberg; Brian Scully; Philip Larussa; Anne A Gershon
Journal:  Am J Infect Control       Date:  2011-01-26       Impact factor: 2.918

4.  Transmission of varicella vaccine virus to a non-family member in China.

Authors:  Lin Gan; Mingli Wang; Sen Yang; Anne A Gershon; Jason J Chen
Journal:  Vaccine       Date:  2010-12-04       Impact factor: 3.641

5.  Identification of five major and two minor genotypes of varicella-zoster virus strains: a practical two-amplicon approach used to genotype clinical isolates in Australia and New Zealand.

Authors:  Vladimir N Loparev; Elena N Rubtcova; Vanda Bostik; Dhwani Govil; Christopher J Birch; Julian D Druce; D Scott Schmid; Margaret C Croxson
Journal:  J Virol       Date:  2007-09-26       Impact factor: 5.103

Review 6.  [Immunization in children and adolescents with rheumatic diseases].

Authors:  K Minden; M Niewerth; M Borte; W Singendonk; J-P Haas
Journal:  Z Rheumatol       Date:  2007-03       Impact factor: 1.372

7.  Challenges with controlling varicella in prison settings: experience of California, 2010 to 2011.

Authors:  Jessica Leung; Adriana S Lopez; Elena Tootell; Nikki Baumrind; Janet Mohle-Boetani; Bruce Leistikow; Kathleen H Harriman; Christopher P Preas; Giorgio Cosentino; Stephanie R Bialek; Mona Marin
Journal:  J Correct Health Care       Date:  2014-09-07

8.  Discriminating between varicella-zoster virus vaccine and wild-type strains by loop-mediated isothermal amplification.

Authors:  Yuki Higashimoto; Masaru Ihira; Akane Ohta; Shigeki Inoue; Chie Usui; Yoshizo Asano; Tetsushi Yoshikawa
Journal:  J Clin Microbiol       Date:  2008-06-11       Impact factor: 5.948

Review 9.  Review of the United States universal varicella vaccination program: Herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project data.

Authors:  G S Goldman; P G King
Journal:  Vaccine       Date:  2012-06-01       Impact factor: 3.641

10.  Transmission of varicella vaccine virus, Japan.

Authors:  Taketo Otsuka; Yasuyuki Gomi; Naoki Inoue; Makoto Uchiyama
Journal:  Emerg Infect Dis       Date:  2009-10       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.